SS
STOK icon

SBI Securities’s Stoke Therapeutics STOK Stock Holding History

SBI Securities’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164 Hold
5
– – ﹤0.01% 3382
2026
Q1 		$163 Hold
5
– – ﹤0.01% 3286
2025
Q4 		$159 Sell
5
-51
-91% -$1.53K ﹤0.01% 3283
2025
Q3 		$1.32K Buy
56
+52
+1,300% +$891 ﹤0.01% 2583
2025
Q2 		$45 Hold
4
– – ﹤0.01% 3746
2025
Q1 		$27 Sell
4
-5
-56% -$47 ﹤0.01% 3794
2024
Q4 		$99 Buy
+9
New +$111 ﹤0.01% 3460

Other funds holding STOK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GIM
Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SBI Securities's STOK Position: Q2 2026 in Review

SBI Securities held its Stoke Therapeutics (STOK) position steady in Q2 2026 at 5 shares worth $164. The position accounts for ﹤0.01% of the portfolio, ranked #3382.

SBI Securities first reported a position in STOK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.32K in Q3 2025. 20 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • SBI Securities held 5 shares of Stoke Therapeutics worth $164 as of Q2 2026.
  • SBI Securities left its Stoke Therapeutics share count unchanged in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3382 holding.
  • SBI Securities first reported a position in Stoke Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Stoke Therapeutics position peaked at $1.32K in Q3 2025.
  • 20 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.